APA (7th ed.) Citation

Chang, Y., Rau, K., Chen, D., Chao, T., Hou, M., & Huang*, C. Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Analysis from EVEREXES Taiwan Subset. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Chang, Yuan-Ching, Kun-Ming Rau, Dar-Ren Chen, Tsu-Yi Chao, Ming-Feng Hou, and Chiun-Sheng Huang*. Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Analysis from EVEREXES Taiwan Subset. Wolters Kluwer Medknow Publications.

MLA (9th ed.) Citation

Chang, Yuan-Ching, et al. Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Analysis from EVEREXES Taiwan Subset. Wolters Kluwer Medknow Publications.